摘要: Xifaxan 550mg片剂获得批准用于降低≥18岁患者的肝性脑病(hepatic encephalopathy,HE)复发的风险.此项批准是基于一项在299例患者中进行的双盲,安慰剂对照,国际多中心Ⅲ期临床试验.该试验证明Xifaxan@550mg片剂在统计学上和临床上均可显著降低HE复发风险.关键词:...
Patients will be randomized to treatment either with rifaximin alone (550 mg twice daily (bid) continuously for a period of 3 months) or with rifaximin (550 mg bid continuously) in combination with lactulose (30–60 ml daily) for 3 months. An esophagogastroduodenoscopy (EGD) will be ...
仿制药参比制剂数据库提供了利福昔明片参比制剂的详细信息,包括美国橙皮书的商品名Rifaximin Tablets,英文名称Rifaximin Tablets,序号,规格,剂型,持证商Salix Pharmaceuticals, Inc.,目录分类等利福昔明片参比制剂的详细信息.
Air flow in entrance 400 ± 100 550 ± 100 350 ± 50 (m3/hour) Air temperature in 60 ± 2 60° C. ± 10 50 ± 2 entrance (° C.) Product temperature 32 25-27 30 ± 2 (° C.) Jet pressure (bar) 1-1.5 ± 0.1 (initial phase) Jet speed (g/min) 150-200...
Dis. 1977, 22, 541–550. [Google Scholar] [CrossRef] Greinert, R.; Zipprich, A.; Simón-Talero, M.; Stangl, F.; Ludwig, C.; Wienke, A.; Praktiknjo, M.; Höhne, K.; Trebicka, J.; Genescà, J.; et al. Covert hepatic encephalopathy and spontaneous portosystemic shunts ...